CME Financials CME Group

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated 55 d ago Overview →

Growth & profitability

Revenue has grown 6.0% per year over the past 5 years.
Net income has grown faster than revenue (14.1% vs 6.0% per year).
Operating margin has expanded, at 64.9% in the latest year.
Free cash flow has grown 10.7% per year over the past 5 years.

Financial health

Operating income covered interest expense 24× in the latest year, up from 16× 5 years ago.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 96.6% of earnings and 93.8% of free cash flow.
The dividend has grown 13.3% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$6.5B	$4.1B	0.0%	64.9%	14.2%	2.1%	$4.2B	—	$4.4B
2024	$6.1B	$3.5B	0.0%	64.1%	13.3%	2.6%	$3.6B	—	$2.9B
2023	$5.6B	$3.2B	0.0%	61.6%	12.1%	2.5%	$3.4B	—	$2.9B
2022	$5.0B	$2.7B	0.0%	60.1%	10.0%	1.5%	$3.0B	—	$2.7B
2021	$4.7B	$2.6B	0.0%	56.4%	9.6%	1.3%	$2.3B	—	$2.8B
2020	$4.9B	$2.1B	0.0%	54.0%	8.0%	1.7%	$2.5B	—	$1.6B
2019	$4.9B	$2.1B	0.0%	53.2%	8.1%	2.8%	$2.4B	—	$1.6B
2018	$4.3B	$2.0B	0.0%	60.5%	7.6%	2.5%	$2.3B	—	$1.4B
2017	$3.6B	$4.1B	0.0%	63.4%	18.1%	5.4%	$1.7B	—	$1.9B
2016	$3.6B	$1.5B	0.0%	61.2%	7.5%	2.2%	$1.6B	—	$1.9B
2015	$3.3B	$1.2B	0.0%	59.8%	6.1%	1.9%	$1.4B	—	$1.7B
2014	$3.1B	$1.1B	0.0%	56.8%	5.4%	1.6%	$1.2B	—	$1.4B
2013	$2.9B	$977M	0.0%	55.8%	4.6%	1.8%	$1.2B	—	$2.5B
2012	$2.9B	$896M	0.0%	58.1%	4.2%	2.3%	$1.1B	—	$1.6B
2011	$3.3B	$1.8B	0.0%	61.6%	8.4%	4.4%	$1.2B	—	$1.0B

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$1.7B	$1.0B	0.0%	64.9%	3.9%	0.5%	$924M	—	$2.1B
Mar '26	$1.9B	—	0.0%	69.7%	0.0%	0.0%	$1.2B	—	$2.4B
Dec '25	$1.6B	—	0.0%	61.8%	0.0%	0.0%	$1.1B	—	$4.4B
Sep '25	$1.5B	—	0.0%	63.3%	0.0%	0.0%	$950M	—	$2.4B
Jun '25	$1.7B	$1.0B	0.0%	66.7%	3.7%	0.6%	$1.0B	—	$2.0B
Mar '25	$1.6B	—	0.0%	67.5%	0.0%	0.0%	$1.1B	—	$1.4B
Dec '24	$1.5B	—	0.0%	62.1%	0.0%	0.0%	$992M	—	$2.9B
Sep '24	$1.6B	—	0.0%	64.6%	0.0%	0.0%	$973M	—	$2.3B
Jun '24	$1.5B	—	0.0%	65.3%	0.0%	0.0%	$759M	—	$1.8B
Mar '24	$1.5B	—	0.0%	64.5%	0.0%	0.0%	$873M	—	$1.4B
Dec '23	$1.4B	—	0.0%	60.0%	0.0%	0.0%	$1.0B	—	$2.9B
Sep '23	$1.3B	—	0.0%	61.3%	0.0%	0.0%	$837M	—	$2.3B
Jun '23	$1.4B	—	0.0%	61.7%	0.0%	0.0%	$630M	—	$1.9B
Mar '23	$1.4B	—	0.0%	63.4%	0.0%	0.0%	$887M	—	$1.6B
Dec '22	$1.2B	$638M	0.0%	55.3%	2.4%	0.4%	$957M	—	$2.7B
Sep '22	$1.2B	$680M	0.0%	60.2%	2.4%	0.4%	$634M	—	$2.1B
Jun '22	$1.2B	$663M	0.0%	60.6%	2.4%	0.4%	$600M	—	$1.9B
Mar '22	$1.3B	$711M	0.0%	63.8%	2.6%	0.3%	$776M	—	$2.0B
Dec '21	$1.1B	$625M	0.0%	55.1%	2.3%	0.3%	$641M	—	$2.8B
Sep '21	$1.1B	$927M	0.0%	55.3%	3.4%	0.5%	$600M	—	$1.5B

Valuation over time

How the market has priced CME against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 25.6× (Mar '23) to 24.9× (Sep '26).
The price-to-sales ratio has risen from 13.7× (Mar '23) to 15.6× (Sep '26).
The dividend yield has risen from 3.8% (Mar '23) to 3.9% (Sep '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is CME growing its revenue and profit?

Over the past 5 years, CME Group's revenue has grown 6.0% per year, and net income grown 14.1% per year. These are computed facts, not advice.

How much debt does CME have?

As of FY2025, CME Group reported — of total debt against $4.4B of cash; operating income covered interest expense 24×.

What is CME's profit margin?

In FY2025, gross margin was —, operating margin 64.9%, and net margin 62.5%.

What is CME's P/E ratio?

As of Sep '26, CME Group traded at a price-to-earnings ratio of about 24.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.